Article
A novel disease-causing CD40L mutation reduces expression of CD40 ligand, but preserves CD40 binding capacity.
Clinical immunology (Orlando, Fla.) - 1 Aug 2014
Günaydin Nurşen C, Chou Janet, Karaca Neslihan E, Aksu Güzide, Massaad Michel J, Azarsiz Elif, Ertan Yesim, Geha Raif S, Kütükçüler Necil
Abstract excerpt
Mutations in CD40 ligand (CD40L) that permit residual CD40L expression typically impair binding of CD40. We report a male patient who presented with recurrent bacterial respiratory tract infections, normal IgM, decreased IgG, absent IgA levels, and CD40L expression at ~50% of the level observed in the normal control. He subsequently developed autoimmunity, inflammatory bowel disease, severe opportunistic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
